VNDA May 2024 3.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 01:44PM EDT. Market open.
| Previous Close | 2.3100 |
| Open | 2.5000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 3.00 |
| Expire Date | 2024-05-17 |
| Day's Range | 2.3100 - 2.5000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
- GuruFocus.com
Vanda Pharmaceuticals Inc (VNDA) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Amidst revenue declines and regulatory hurdles, Vanda Pharmaceuticals strategizes on new drug applications and market expansions.
PR NewswireVanda Pharmaceuticals Reports First Quarter 2024 Financial Results
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2024.
- PR Newswire
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that it has received a revised unsolicited proposal from Future Pak, LLC ("Future Pak") to acquire the Company. The revised proposal consists of a $7.25 to $7.75 per share in cash plus certain Contingent Value Rights ("CVRs"). The amended proposal follows Vanda's review and rejection of a prior unsolicited proposal from Future Pak to acquire the Company for $7.25-$7.75 per share.
© 2024 Yahoo. All rights reserved.